120 related articles for article (PubMed ID: 7891828)
21. Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor.
Tomidokoro Y; Harigaya Y; Matsubara E; Ikeda M; Kawarabayashi T; Okamoto K; Shoji M
Neurosci Lett; 2000 Oct; 292(3):155-8. PubMed ID: 11018300
[TBL] [Abstract][Full Text] [Related]
22. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?
Bons N; Rieger F; Prudhomme D; Fisher A; Krause KH
Genes Brain Behav; 2006 Mar; 5(2):120-30. PubMed ID: 16507003
[TBL] [Abstract][Full Text] [Related]
23. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus.
Bons N; Mestre N; Petter A
Neurobiol Aging; 1992; 13(1):99-105. PubMed ID: 1542387
[TBL] [Abstract][Full Text] [Related]
24. Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate.
Canron MH; Perret M; Vital A; Bézard E; Dehay B
Sci Rep; 2012; 2():910. PubMed ID: 23205271
[TBL] [Abstract][Full Text] [Related]
25. Distribution of lithostathine in the mouse lemur brain with aging and Alzheimer's-like pathology.
Marchal S; Givalois L; Verdier JM; Mestre-Francés N
Neurobiol Aging; 2012 Feb; 33(2):431.e15-25. PubMed ID: 21371784
[TBL] [Abstract][Full Text] [Related]
26. Modeling the Interaction between β-Amyloid Aggregates and Choline Acetyltransferase Activity and Its Relation with Cholinergic Dysfunction through Two-Enzyme/Two-Compartment Model.
Fgaier H; Mustafa IH; Awad AA; Elkamel A
Comput Math Methods Med; 2015; 2015():923762. PubMed ID: 26413144
[TBL] [Abstract][Full Text] [Related]
27. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
[TBL] [Abstract][Full Text] [Related]
28. Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.
Michalski D; Hofmann S; Pitsch R; Grosche J; Härtig W
J Alzheimers Dis; 2017; 59(2):655-674. PubMed ID: 28671120
[TBL] [Abstract][Full Text] [Related]
29. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.
Nagele RG; D'Andrea MR; Lee H; Venkataraman V; Wang HY
Brain Res; 2003 May; 971(2):197-209. PubMed ID: 12706236
[TBL] [Abstract][Full Text] [Related]
30. Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis.
Lamarca MV; Fibiger HC
Brain Res; 1984 Jul; 307(1-2):366-9. PubMed ID: 6540615
[TBL] [Abstract][Full Text] [Related]
31. Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus.
Nag S; Tang F
Neurosci Lett; 1998 Aug; 252(2):83-6. PubMed ID: 9756327
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles.
Mestre-Francés N; Keller E; Calenda A; Barelli H; Checler F; Bons N
Neurobiol Dis; 2000 Feb; 7(1):1-8. PubMed ID: 10671318
[TBL] [Abstract][Full Text] [Related]
33. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
34. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease.
Behrouz N; Defossez A; Delacourte A; Mazzuca M
J Gerontol; 1991 Nov; 46(6):B209-12. PubMed ID: 1719062
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin alterations and brain diseases.
Epelbaum J; Agid Y; Enjalbert A; Hamon M; Javoy-Agid F; Kordon C; Lamour Y; Moyse E
Adv Exp Med Biol; 1985; 188():261-74. PubMed ID: 2863935
[No Abstract] [Full Text] [Related]
36. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M
J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747
[TBL] [Abstract][Full Text] [Related]
37. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain.
Beeson JG; Shelton ER; Chan HW; Gage FH
J Comp Neurol; 1994 Apr; 342(1):69-77. PubMed ID: 8207128
[TBL] [Abstract][Full Text] [Related]
38. Distinct transcriptome expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer's disease-like pathology.
Abdel Rassoul R; Alves S; Pantesco V; De Vos J; Michel B; Perret M; Mestre-Francés N; Verdier JM; Devau G
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862281
[TBL] [Abstract][Full Text] [Related]
39. Linking cognition to age and amyloid-β burden in the brain of a nonhuman primate (Microcebus murinus).
Schmidtke D; Zimmermann E; Trouche SG; Fontès P; Verdier JM; Mestre-Francés N
Neurobiol Aging; 2020 Oct; 94():207-216. PubMed ID: 32650184
[TBL] [Abstract][Full Text] [Related]
40. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
